Jeffrey W. Runge, Director at PHARMATHENE, INC (PIP), bought 20,000 shares at $1.30 ($26K) on 2011-12-12, disclosed to the SEC on 2011-12-14.
Open-market purchase of $26k PIP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |